Summary:
- The article discusses the phenomenon of "Ozempic babies," where individuals using GLP-1 receptor agonists (like semaglutide) unexpectedly conceive despite previous fertility struggles.
- It explores the potential biological mechanisms behind this, specifically how improved metabolic health and weight loss can restore ovulation and hormonal balance in patients with conditions like Polycystic Ovary Syndrome (PCOS).
- It highlights expert cautions from the medical community regarding the lack of long-term data on the safety of these medications during pregnancy, emphasizing the importance of discontinuing use well before conception.